Marco Brugnoli is the Chief Executive Officer of COSMED HQ, Italy, a globally recognized leader in cardiopulmonary, metabolic, and body composition diagnostic technologies. Based in Italy, COSMED develops advanced solutions used worldwide in clinical practice, scientific research, and human performance assessment.

Marco Brugnoli will share insights on how cutting-edge diagnostic technologies and metabolic assessment can contribute to longevity science, preventive health strategies, and improved quality of life across populations.